At the European Association for the Study of Diabetes meeting, Louis J. Aronne, MD, argued that obesity medications could make bariatric surgery obsolete, thanks to drugs that treat multiple metabolic conditions. Francesco Rubino, MD, countered, suggesting “metabolic” surgery will continue to play a key role, especially for long-term management of obesity and related conditions. Aronne believes future treatments will address obesity earlier, while Rubino sees surgery remaining important for certain patients. Both agree obesity management is evolving rapidly.
Trending
- Evaluating the analytical performance of direct-to-consumer gut microbiome testing services (Nature)
- Resecting a Rectal Carcinoid (GI & Endoscopy News)
- AI blood test detects early pancreatic cancer with up to 94% accuracy (Medical Xpress)
- Why 2026 is a reset year for U.S. health care (Medical Economics)
- The “Dream Team” for Managing IBS-C Needs GI Psychologist and Dietician (Gastroenterology Learning Network)
- March 2026 issue Of The American Journal of Gastroenterology (The American Journal of Gastroenterology)
- The GI physician shortage by state, by 2036 (Becker’s GI & Endoscopy)
- PAGI Joins UPMC to Expand Access to Specialized Gastroenterology Care in Central Pa. (UPMC)
